Innovation Pharmaceuticals Inc (IPIX)

[1oldprof]

Brilacidin is brilacidin. If you modify it, it is not brilacidin anymore. That said, utilizing the artificial polymeric backbone of B, it could be modified to address different applications, which is part of what the UPenn folks did, as long as the biochemical pathways are worked out and the stereochemical relationships between receptor and ligand are known. Knowing these relationships would make it a much more refined process and not as much hit and miss. Absolutely last post here. I know what I have and liking it